Navigation Links
Schering-Plough Reports Financial Results for 2009 Second Quarter
Date:7/21/2009

merger and acquisition-related items and other specified items $136 $307 $305 $893 ==== ==== ==== ==== (a) Included in cost of sales (b) Included in cost of sales, selling, general and administrative and research and development (c) Included in other expense (income), net (d) Included in special, merger and acquisition-related charges (e) Included in research and development (f) Included in equity income

    SCHERING-PLOUGH CORPORATION

    Report for the period ended June 30 (unaudited):

    GAAP Net Sales by Key Product

    (Dollars in millions)         Second Quarter            Six Months
                                  --------------            ----------
                                   2009   2008      %     2009    2008    %
                                   ----   ----      -     ----    ----    -

    PRESCRIPTION PHARMACEUTICALS $3,589 $3,702     (3%) $6,968  $7,259   (4%)
       REMICADE                     565    557       2%  1,083   1,064     2%
       NASONEX                      321    311       3%    627     618     1%
       TEMODAR                      256    251       2%    503     487     3%
       PEGINTRON                    215    229     (6%)    430     454   (5%)
       CLARINEX / AERIUS            226    240     (6%)    400     454  (12%)
       FOLLISTIM / PUREGON          145    162    (11%)    275     308  (10%)
       NUVARING                     129    116      11%    244     212    15%
       CLARITIN Rx                   96    111    (13%)    228     239   (4%)
       AVELOX                        71     67       7%    180     209  (14%)
       INTEGRILIN                    73     78     (7%)    149     152   (2%)
       REBETOL                       67     70     (4%)    134     130     3%
       CAELYX                        68   
'/>"/>
SOURCE Schering-Plough Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27

Related biology technology :

1. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
2. Schering-Plough Announces Pricing of Senior Notes Offering
3. Schering-Plough to Webcast Presentation at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
4. Schering-Plough Receives Approval from European Commission for Planned Acquisition of Organon BioSciences N.V.
5. Schering-Plough Completes Acquisition of Organon BioSciences
6. Schering-Plough Wins Three of Scrips Top Pharma Industry Awards
7. Schering-Plough Schedules Conference Call and Webcast for 2007 Fourth Quarter, Full-Year Financial Result
8. Schering-Plough to Webcast Presentation at Morgan Stanley Pharmaceutical CEOs Unplugged Conference
9. Schering-Plough Announces New Drug Application for Sugammadex Assigned Priority Review Status by U.S. FDA
10. Schering-Plough Announces Sugammadex New Drug Application Filed in Japan
11. FDA Grants Priority Review for Schering-Ploughs Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... Massachusetts (PRWEB) October 22, 2014 ... announced the release of a new infographic, Understanding ... to create a beautifully designed, easy to follow informative ... transmission, areas of outbreak, symptoms and prevention. , "As ... discovered that the 2014 Ebola outbreak represents not only ...
(Date:10/22/2014)... 22, 2014 According to new ... Service Type (Consulting, Integration, Deployment & Support), by ... Model (Public, Private, Others (Hybrid & Community)) - ... and segments the Cloud Professional Services Market into ... of revenues. It also identifies the drivers and ...
(Date:10/22/2014)... HONG KONG , Oct. 22, 2014  aTyr ... today that rare disease expert John C. McKew ... Dr. McKew brings more than two decades of expertise ... National Institutes of Health, Wyeth Research and Genetics Institute, ... lead aTyr,s efforts to expand and translate its novel ...
(Date:10/20/2014)... Oct. 20, 2014 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or ... brings Q3 orders to $5.8 million and provides a good start ... North America and one in the ... new projects at record levels," said Peter Bruijns , President ... the end of Q3 than they have been for any complete ...
Breaking Biology Technology:Involution Studios' Ebola Infographic Provides Key Disease Information and Statistics at a Glance 2Cloud Professional Services Market by Public, Private, Hybrid & Community Expected to Reach $34.41 Billion by 2019 - New Report by MarketsandMarkets 2Cloud Professional Services Market by Public, Private, Hybrid & Community Expected to Reach $34.41 Billion by 2019 - New Report by MarketsandMarkets 3Cloud Professional Services Market by Public, Private, Hybrid & Community Expected to Reach $34.41 Billion by 2019 - New Report by MarketsandMarkets 4Cloud Professional Services Market by Public, Private, Hybrid & Community Expected to Reach $34.41 Billion by 2019 - New Report by MarketsandMarkets 5aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 3
... 24, 2011 Accera, Inc., a biotech ... has donated $50,000 to the Alzheimer,s Foundation of America ... (NMSD) during National Alzheimer,s Disease Awareness Month.  These funds ... educate and support individuals with Alzheimer,s disease (AD) and ...
... Protein Corporation (NYSE symbol: OME), a nutritional ingredient company ... and specialty fish meal products, today announced that it ... in connection with its omega-3 fish oil and omega-3 ... is an analytical services and biotechnology consulting company that ...
... Silence Therapeutics plc (AIM: SLN) ("Silence"), a ... that it has entered into an agreement with ... microRNA-based therapeutics for cancer, to assess the delivery ... systems for Mirna,s novel microRNAs. Under ...
Cached Biology Technology:Accera, Inc. Donates $50,000 to the Alzheimer's Foundation of America for National Memory Screening Day 2Accera, Inc. Donates $50,000 to the Alzheimer's Foundation of America for National Memory Screening Day 3Omega Protein Announces Retention of Lipid Technologies, LLC 2Silence Therapeutics Signs Collaboration With Mirna Therapeutics to Evaluate Delivery of Novel microRNA Therapeutics 2Silence Therapeutics Signs Collaboration With Mirna Therapeutics to Evaluate Delivery of Novel microRNA Therapeutics 3Silence Therapeutics Signs Collaboration With Mirna Therapeutics to Evaluate Delivery of Novel microRNA Therapeutics 4Silence Therapeutics Signs Collaboration With Mirna Therapeutics to Evaluate Delivery of Novel microRNA Therapeutics 5Silence Therapeutics Signs Collaboration With Mirna Therapeutics to Evaluate Delivery of Novel microRNA Therapeutics 6
(Date:10/18/2014)... and stress-related psychiatric disorders are associated with ... molecular mechanisms underlying this relation are unknown. ... development of targeted preventive strategies and new ... This work is presented at the European ... an international group of researchers from Germany ...
(Date:10/17/2014)... for the first time how bacteria can grow directly ... the opportunity to get tremendous insights into bacteria behavior ... discovered the bacterial growth in chronic lung infections among ... by the immune cells. The researchers discovered the immune ... bacteria, forcing the bacteria to switch to a much ...
(Date:10/16/2014)... the bowel lining develops and, in the process, suggested ... The researchers produced evidence that stem cells are responsible ... feature of the bowel lining, and believe these stem ... finding as scientists are still divided on the stem ... Wee Tan and Professor Tony Burgess from the Walter ...
Breaking Biology News(10 mins):Researchers find why depression and aging linked to increased disease risk 2Scientists opens black box on bacterial growth in cystic fibrosis lung infection 2Cryptic clues drive new theory of bowel cancer development 2
... American ecosystems over the past 150 years have caused coyotes ... southwestern deserts of North America to habitats throughout the United ... in the Journal of Mammalogy , researchers from the ... used DNA from coyote scat (feces) to trace the route ...
... The fictitious storybook character Dr. Doolittle was ... an assistant professor of psychology at Rochester Institute ... focuses on object discrimination in goldfish and echolocation ... the mysteries of animal perception and cognition. ...
... to trick ourselves into believing we are full even as our ... the November issue of the Cell Press journal Cell Metabolism ... to go with our guts just two gut hormones, that ... could be the long-sought answer to healthy eating, according to the ...
Cached Biology News:New genetic evidence confirms coyote migration route to Virginia and hybridization with wolves 2Go fish! RIT psychology professor trains goldfish for object perception research 2Simple gut hormone combo makes our brains think we're full 2
... the premium quality siRNAs you need for ... be readily ordered online by providing either ... providing the sense and antisense siRNA sequences. ... Silencer Pre-designed siRNAs, which are already designed ...
Request Info...
Bovine Serum Albumin Heat Shock Diagnostic Grade Powder...
, Premium quality synthesis and purification , You provide the sequence, we'll do the rest , Rigorous quality control , Your choice of purification method, amount and format , Available annealed...
Biology Products: